Patent intelligence · Companies
Company patent strength
Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead — toggle to foreign applicants to see who is entering the Indian market.
Free to browse the ranking. Sign into open a filer's full profile — inventors, filing trend and quality index. See how we rank.
Why this page exists — and how to read it
Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.
- Investors
- High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
- Founders & operators
- These are the incumbents and potential acquirers in your space — open a filer to see the walls you'd build against.
- Corporate & R&D
- Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.
💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.
3,207 foreign filers with 5+ patents · page 57
| # | Filer | Patents↓ | Granted↓ | Lapsed↓ | Pending↓ | Active |
|---|---|---|---|---|---|---|
| 2801 | FM ENERGIE KG | 5 | 00% | 0 | 5 | 2022–2025 |
| 2802 | FOCAL POINT POSITIONING | 5 | 00% | 0 | 5 | 2024–2025 |
| 2803 | FORTEPHEST | 5 | 00% | 1 | 4 | 2022–2026 |
| 2804 | FORTVITA BIOLOGICS SINGAPORE | 5 | 00% | 0 | 5 | 2024–2026 |
| 2805 | FRATELLI CECCATO MILANO S R L | 5 | 00% | 0 | 5 | 2022–2025 |
| 2806 | FUKUDA METAL FOIL POWDER | 5 | 00% | 0 | 5 | 2024–2026 |
| 2807 | FURANIX TECHNOLOGIES | 5 | 360% | 0 | 2 | 2022–2023 |
| 2808 | FURUKAWA ELECTRIC LATAM | 5 | 240% | 0 | 3 | 2022–2022 |
| 2809 | FUSION PHARMACEUTICALS | 5 | 00% | 1 | 4 | 2022–2026 |
| 2810 | FUTAMURA CHEMICAL UK | 5 | 00% | 0 | 5 | 2022–2025 |
| 2811 | G2GBIO | 5 | 240% | 0 | 3 | 2022–2025 |
| 2812 | GALAPAGOS | 5 | 00% | 0 | 5 | 2023–2025 |
| 2813 | GALDERMA HOLDING | 5 | 00% | 0 | 5 | 2024–2025 |
| 2814 | GAN LEE PHARMACEUTICALS | 5 | 00% | 1 | 4 | 2022–2026 |
| 2815 | GASHERBRUM BIO | 5 | 00% | 0 | 5 | 2022–2026 |
| 2816 | GE GRID SOLUTIONS | 5 | 360% | 0 | 2 | 2018–2025 |
| 2817 | GE INTELLECTUAL PROPERTY LICENSING | 5 | 00% | 0 | 5 | 2024–2025 |
| 2818 | GEA TUCHENHAGEN | 5 | 00% | 0 | 5 | 2022–2024 |
| 2819 | GEBR PFEIFFER SE | 5 | 120% | 0 | 4 | 2022–2026 |
| 2820 | GENEQUANTUM HEALTHCARE SUZHOU | 5 | 00% | 0 | 5 | 2024–2025 |
| 2821 | GENFLEET THERAPEUTICS SHANGHAI | 5 | 00% | 0 | 5 | 2024–2026 |
| 2822 | GEOBRUGG | 5 | 360% | 0 | 2 | 2022–2025 |
| 2823 | GERON | 5 | 120% | 0 | 4 | 2022–2025 |
| 2824 | GFM | 5 | 240% | 1 | 2 | 2022–2023 |
| 2825 | GI INNOVATION | 5 | 00% | 0 | 5 | 2022–2024 |
| 2826 | GIESECKE DEVRIENT MOBILE SECURITY | 5 | 00% | 2 | 3 | 2022–2023 |
| 2827 | GIULIANI | 5 | 00% | 0 | 5 | 2024–2025 |
| 2828 | GLOBAL MOBILITY SERVICE | 5 | 120% | 0 | 4 | 2020–2025 |
| 2829 | GNOTHIS HOLDING | 5 | 00% | 0 | 5 | 2025–2025 |
| 2830 | GOGLIO | 5 | 00% | 0 | 5 | 2022–2024 |
| 2831 | GOOD WATER ENERGY | 5 | 00% | 0 | 5 | 2023–2026 |
| 2832 | GPCP IP HOLDINGS | 5 | 00% | 3 | 2 | 2022–2024 |
| 2833 | GUALA CLOSURES | 5 | 00% | 0 | 5 | 2022–2026 |
| 2834 | GUANGDONG FAPON BIOPHARMA | 5 | 00% | 0 | 5 | 2023–2026 |
| 2835 | GUANGZHOU CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY | 5 | 00% | 0 | 5 | 2023–2025 |
| 2836 | GUANGZHOU JOYO PHARMATECH | 5 | 240% | 0 | 3 | 2022–2026 |
| 2837 | GUNZE | 5 | 120% | 0 | 4 | 2022–2025 |
| 2838 | H GAN S PUBL | 5 | 00% | 0 | 5 | 2023–2026 |
| 2839 | H LUNDBECK A S | 5 | 120% | 0 | 4 | 2021–2025 |
| 2840 | H NEL KG | 5 | 00% | 0 | 5 | 2023–2026 |
| 2841 | HABASIT | 5 | 120% | 0 | 4 | 2021–2024 |
| 2842 | HANGZHOU DAC BIOTECH | 5 | 120% | 0 | 4 | 2022–2024 |
| 2843 | HANGZHOU SCIWIND BIOSCIENCES | 5 | 120% | 0 | 4 | 2022–2025 |
| 2844 | HARCROS CHEMICALS | 5 | 00% | 0 | 5 | 2023–2026 |
| 2845 | HARIMA CHEMICALS | 5 | 120% | 0 | 4 | 2022–2026 |
| 2846 | HEAT AND CONTROL | 5 | 00% | 0 | 5 | 2022–2025 |
| 2847 | HELIOS PROJECT | 5 | 00% | 1 | 4 | 2022–2026 |
| 2848 | HELIX NANOTECHNOLOGIES | 5 | 00% | 0 | 5 | 2023–2025 |
| 2849 | HEMOTEQ | 5 | 00% | 0 | 5 | 2023–2026 |
| 2850 | HERAEUS DEUTSCHLAND KG | 5 | 00% | 1 | 4 | 2022–2023 |
Educational institutes are excluded — see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →
Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy — directional, not advice; see methodology. Read the ranking methodology →